// App-Quantinova.ai

: SECOND ALLOGENEIC STEM CELL TRANSPLANTATION WITH HAPLOIDENTICAL GRAFTS FOR POST-TRANSPLANT RELAPSE

Researchers

Presenter

  • Samer A. Srour

Principal Investigators

  • Piyanuch Kongtim

  • Julianne Chen

  • Gabriela Rondon

  • Chitra Hosing

  • Uday Popat

  • Qaiser Bashir

  • Muzaffar Qazilbash

  • Partow Kebriaei

  • Demetrios Petropoulos

  • Richard Champlin

  • Stefan Ciurea

Medical Centers

  • Stem cell transplantationa and cellular therapy, The university of Texas MD Anderson Cancer Center, Houston, TX, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Alpha-thalassemia myelodysplasia syndrome

  • Acute myelocytic leukemia

  • Hodgkin's Lymphoma

  • Lymphomas

Biomarkers

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved